Loading viewer...
investor_presentation
Format: PDF investor_presentation
Investor presentation for Sustained Embolic Protection covering company and product overview as of March 2023. The presentation discusses forward-looking statements, market opportunities, and commercialization plans for the company's medical device products, while outlining key leadership and organizational structure.
investor_presentation
27 Pages
Regeneron Pharmaceuticals, Inc.